Francis Willard Sarena

Insider Reports History

Entity
Individual
Location
C/O Five Prime Therapeutics, Inc., 2 Corporate Drive, South San Francisco, CA
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Francis Willard Sarena
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Francis Willard Sarena:

Stock Role Class Num Shares Value Price $ Report Date Ownership
89bio, Inc. Chief Operating Officer Common Stock 78.8K $689K $8.75 Feb 1, 2025 Direct
89bio, Inc. Chief Operating Officer Stock Option (Right to Buy) 215K Feb 1, 2025 Direct
Apexigen, Inc. President and COO Common Stock 0 $0.39 Aug 23, 2023 Direct
Apexigen, Inc. President and COO Employee Stock Option (right to buy) 0 Aug 23, 2023 Direct

Insider Reports Filed by Francis Willard Sarena

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ETNB 89bio, Inc. Feb 1, 2025 2 $0 4 Feb 4, 2025 Chief Operating Officer
ETNB 89bio, Inc. Aug 5, 2024 2 $0 4 Aug 7, 2024 Chief Operating Officer
ETNB 89bio, Inc. Jul 30, 2024 0 $0 3 Aug 7, 2024 Chief Operating Officer
APGN Apexigen, Inc. Aug 23, 2023 3 -$12K 4 Aug 25, 2023 President and COO
APGN Apexigen, Inc. Jun 15, 2023 1 -$3.4K 4 Jun 23, 2023 President and COO
APGN Apexigen, Inc. May 23, 2023 2 -$8.3K 4 May 25, 2023 President and COO
APGN Apexigen, Inc. Dec 15, 2022 1 -$7.33K 4 Dec 19, 2022 Chief Operating Officer
APGN Apexigen, Inc. Oct 7, 2022 1 $0 4 Oct 11, 2022 Chief Operating Officer
APGN Apexigen, Inc. Jul 29, 2022 0 $0 3 Aug 8, 2022 Chief Operating Officer